30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: ConMed

$105.9MM, +2%

  • Musculoskeletal Transplant Foundation (MTF)-related revenue -18%
  • Powered Instruments +4%
  • MTF revenue impacted by anticipated supplier inability to supply PRP devices for resale, may discontinue product
  • Y-Knot Flex system exceeding forecasts
  • Launching 5 orthopaedic products in 2014, including Edge Ablation system for limited ex-U.S. launch in 2Q, U.S. launch 3Q
  • Introducing new bone void filler with MTF, adding 100% demineralized cortical bone
  • Reports surfaced during 2Q that company was exploring sale, hired advisors